Intuitive Surgical, Inc. $ISRG Shares Sold by ING Groep NV

ING Groep NV lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.4% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 198,766 shares of the medical equipment provider’s stock after selling 9,107 shares during the quarter. Intuitive Surgical comprises about 0.7% of ING Groep NV’s investment portfolio, making the stock its 28th largest position. ING Groep NV’s holdings in Intuitive Surgical were worth $112,573,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Capital World Investors boosted its position in shares of Intuitive Surgical by 1.7% in the fourth quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock worth $4,449,491,000 after buying an additional 127,526 shares during the period. Capital International Sarl boosted its position in shares of Intuitive Surgical by 6.1% in the fourth quarter. Capital International Sarl now owns 114,521 shares of the medical equipment provider’s stock worth $64,860,000 after buying an additional 6,598 shares during the period. Capital International Ltd. CA boosted its position in shares of Intuitive Surgical by 1.7% in the fourth quarter. Capital International Ltd. CA now owns 65,276 shares of the medical equipment provider’s stock worth $36,970,000 after buying an additional 1,074 shares during the period. Capital Group Investment Management PTE. LTD. boosted its position in shares of Intuitive Surgical by 2.1% in the fourth quarter. Capital Group Investment Management PTE. LTD. now owns 14,315 shares of the medical equipment provider’s stock worth $8,107,000 after buying an additional 294 shares during the period. Finally, Los Angeles Capital Management LLC boosted its position in shares of Intuitive Surgical by 1,004.8% in the fourth quarter. Los Angeles Capital Management LLC now owns 46,103 shares of the medical equipment provider’s stock worth $24,436,000 after buying an additional 41,930 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 500 shares of the firm’s stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the transaction, the director directly owned 239 shares in the company, valued at $113,156.94. This trade represents a 67.66% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 7,448 shares of company stock valued at $3,224,404. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $422.06 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $396.68 and a fifty-two week high of $603.88. The stock’s 50-day moving average is $447.24 and its two-hundred day moving average is $501.02. The firm has a market cap of $149.48 billion, a P/E ratio of 51.16, a price-to-earnings-growth ratio of 3.37 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. During the same period last year, the company earned $1.81 earnings per share. The business’s revenue was up 23.0% compared to the same quarter last year. On average, equities analysts expect that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Analysts Set New Price Targets

ISRG has been the subject of several recent analyst reports. HSBC decreased their target price on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Barclays set a $651.00 target price on Intuitive Surgical and gave the stock an “overweight” rating in a research report on Thursday, April 23rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research report on Tuesday, May 19th. BTIG Research reaffirmed a “buy” rating and issued a $574.00 target price on shares of Intuitive Surgical in a research report on Wednesday, April 22nd. Finally, JPMorgan Chase & Co. reduced their price objective on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Nineteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $573.63.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.